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Abstract
In addition to signaling pathways, transcription factors and epigenetic regulators, microRNAs (miRNAs) are 
emerging as important regulators of human pluripotent stem cells (hPSCs). Pluripotent miRNAs that regulate G1-S 
transition and pluripotency factors to maintain self-renewal have been identified. However, only 4-5 clusters of miRNAs 
have been identified in human embryonic stem cells (hESCs). We performed cell cycle phase-based (G1, S and G2/M 
phases) miRNA array in pluripotent and differentiated hESCs. We demonstrated that embryonic stem cell-cell cycle 
(ESCC) regulating miRNAs were all highly expressed in three cell cycle phases of undifferentiated hESCs suggesting a 
non-cell phase regulated mechanism. From cell phase-dependent miRNAs, G2/M-miRNAs was extracted by principle 
component analysis (PCA) as a significant component in pluripotent hESCs, whereas G1-miRNAs was a significant 
component in differentiated hESCs. The results indicate that G2/M-miRNAs might function to maintain pluripotency and 
G1-miRNAs might function to enhance differentiation. By miRNA target site prediction, G2/M-phase miRNA displayed 
potential target sites on differentiation factors GATA6 and GATA4, G1-phase miRNAs displayed potential target sites 
on pluripotency gene OCT4, NANOG and SOX2, which warrant further confirmation and functional study. By statistical 
and computation analysis of the miRNA array data, we demonstrated that the G2/M-miRNAs could potentially repress 
differentiation factors to maintain pluripotency and G1-miRNAs could potentially target pluripotency genes to enhance 
differentiation.
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Introduction
Pluripotent stem cells (PSCs) are defined by their capacity to 
undergo indefinite self-renewal and to differentiate into all somatic 
cell lineages and germ cells [1], which includes embryonic stem cells 
(ESCs) and induced pluripotent stem cells (iPSCs). PSCs have unique 
cell cycle characteristics; cycling cells have a short G1 phase and a large 
percentage of S phase cells, whereas upon induction of differentiation 
the G1 phase lengthens and the fraction of cells in S phase is reduced 
[2]. G1 cells are prone to differentiation signaling cues, such as retinoic 
acid (RA), while S phase cells are refractory to this RA signal [3]. 
More importantly, the transcript levels of developmental genes have 
been found to be cell cycle regulated, peaking in G1 and declining 
in S phase, respectively [4]. Thus, G1 is the cell fate decision-making 
point; when pluripotent cells enter into G1, they become “poised” and 
permissive to either continued self-renewal or commitment to lineage 
specification [4]. 
Small non-coding RNAs, the microRNA (miRNA) superfamily 
has been revealed as a new class of stem cell lineage determiners. Like 
transcription factors, a single miRNA can regulate the target gene 
products. Among miRNAs expressed in ESCs, the conserved miR-
302/367 cluster is highly expressed and has the most functional impact. 
Another less conserved miRNA cluster for ESCs is the miR-290-292 
cluster in mESCs and miR-371-373 cluster in mEpiSCs/hESCs. Dicer 
and Dgcr are required for the processing of mature miRNA. Dicer 
and Dgcr8 knockout mESCs and hESCs exhibit proliferation and cell 
cycle G1-S transition defects, whereas miR-302 and miR-290 clusters 
can partially rescue these defects. Thus, these miRNAs are also called 
embryonic stem cell-cell cycle regulating (ESCC) miRNAs. All these 
miRNAs are highly expressed in undifferentiated ESCs and decline 
upon differentiation, which indicates a specific function for these 
miRNAs in ESCs [5-12].
During differentiation, ESCs shift to alternative molecular 
programs to inhibit self-renewal and coordinate differentiation into 
highly specialized cell types. A direct way to silence the self-renewal is 
to repress the pluripotency transcription factors such as OCT4, SOX2 
and NANOG [8]. MiR-145 specifically binds the 3’UTR of OCT4 to 
repress pluripotency in hESCs. MiR-145 also directly regulates SOX2 
and KLF4 [13]. Another group of pluripotency-silencing miRNAs 
are the let-7 family, which are widely expressed in various somatic 
tissues. Let-7 is repressed in ESCs but rapidly upregulated during ESC 
differentiation. The let-7 family directly targets hundreds of members 
of the pluripotency network including c-Myc, Sall4, and Lin28 to 
induce differentiation [14]. On the other hand, the ESCC miRNAs 
indirectly upregulate many of these same let-7 targets [14]. Although 
exactly how the ESCC miRNAs are functionally dominant over let-7 
remains unknown; that the ESCC miRNAs can upregulate Lin28, which 
negatively regulates the maturation of the let-7 family of miRNAs is 
likely part of the mechanism [5,9]. Thus, the ESCC miRNAs and several 
differentiation-inducing miRNAs provide contrasting mechanisms to 
monitor the cell cycle and self-renewal of ESCs [5]. 
Pluripotent miRNAs that are highly expressed in ESCs have been 
identified. These miRNAs regulate G1-S transition and directly or 
indirectly regulate pluripotency factors to maintain the self-renewal. 
However, only 4-5 clusters of either pluripotency maintaining miRNAs 
or pluripotency-silencing miRNAs have been identified in hESCs. In 
our present study, we performed cell cycle phase-based (G1, S and 
G2/M phases) miRNA array on pluripotent and differentiated hESCs, 
Heatmap and principal components analysis (PCA) to organize and 
visualize miRNA array data, and PCA-SPSS to extract common factors 
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among cell-phase miRNA variables. We demonstrated cell cycle-
phase specific miRNAs. The G2/M-miRNAs could potentially repress 
differentiation factors to maintain pluripotency and G1-miRNAs could 
potentially target pluripotency genes to enhance differentiation.
Materials and Methods
Cell culture
The hESC line H1 was maintained in feeder-free mTeSR1 or E8 
medium (Stem Cell Technology, Vancouver, Canada) on Matrigel (BD 
Biosciences, San Jose, CA, USA) or Geltrex (Invitrogen, Carlsbad, CA 
USA) at 37ºC in a humidified atmosphere of 5% CO2. Medium was 
changed daily with daily. 2–5 μM of retinoic acid (Sigma-Aldrich, 
St. Louis, MO, USA) was added to hESCs for 2-3 days for in vitro 
differentiation [15]. 
Flow cytometry and cell sorting
To obtain cell cycle-based cell fractions, H1 cells in pluripotency 
and differentiated states were harvested and fixed in cold 80% ethanol 
followed by staining with propidium iodide (PI) for cell cycle analysis as 
described previously [16,17]. G1, S and G2/M cells were sorted out based 
on DNA content using BD FACSAria I Cell Sorter (BD Biosciences). 
Sorted G1, S and G2/M cell pellets were frozen immediately at −70ºC 
for RNA extraction.
RNA extraction and miRNA cDNAs reverse transcription
Total RNA was extracted using RNAiso Plus (total RNA extraction 
reagent, Takara, Shiga, Japan), a representative Trizol reagent. Total RNA 
was suspended in Invitrogen UltraPure DNase/RNase-free distilled 
water (Invitrogen). The RNA concentrations were determined using 
NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, 
Wilmington, DE, USA). 
miRNAs cDNAs reverse transcription
800 ng of total RNA from each cell phase was applied to reverse 
transcribe mRNA to complementary DNA (cDNA) using Megaplex 
reverse transcription (RT) primers and TaqMan microRNA RT kit 
(Applied Biosystems, Foster City, CA, USA) following manufacturer’s 
instructions. Megaplex primers enhance the ability to detect low 
expression of miRNAs and TaqMan only quantitate specific mature 
miRNAs, not precursors. 
TaqMan human microRNA array analysis 
Synthesized miRNA cDNA were applied to quantify miRNAs 
expression using the TaqMan® Array Human microRNA A and B 
Cards Set v2.0 (Applied Biosystems). Loading of the A and B cards and 
running the arrays on the 7900H fast real-time PCR system followed 
the manufacturer’s instructions. The miRNA array A+B card sets 
cover 667 of human miRNAs. Ct values were used to present miRNA 
expression levels. For differential miRNA expression amongst cell cycle 
phases, ΔΔCt was calculated as fold change versus cell phase with the 
lowest level of miRNA. 
Statistical analysis
A web tool ClustVis [18] was used for HeatMap and PCA to organize 
and visualize miRNA array data. SPSS 21 (IBM Corp., Armonk, NY, 
USA) was applied to perform PCA. Bartlett’s test sphericity with an 
associated p value was <0.001 before further valid factor analysis. 
Rotated component matrix was used to interpret the component.
Results
Cell cycle phase-based ESCC miRNA profile 
Undifferentiated and differentiated cycling hESC line H1 cells were 
sorted by flow cytometry into G1, S and G2/M cohorts, respectively, 
according to DNA content (Figure 1A). Cell cycle phase-based miRNA 
profiles were detected using TaqMan human microRNA array analysis. 
ESCC miRNAs are pluripotent miRNAs regulating G1-S transition, 
although it is not known whether ESCC miRNAs function in cell 
phase-based pattern. We firstly characterized ESCC miRNA levels in 
each cell cycle. ESCC miRNA expression levels can clearly separate 
pluripotency and differentiated hESC population according to PCA 
(Figure 1B), with ESCC miRNAs were highly expressed in pluripotent 
hESC cells (Figure 1C, left panel), whereas significantly down-regulated 
during differentiation (Figure 1C, right panel). We also noticed that 
the ESCC or ESCC-related miRNA, such as miR-302-367 cluster, were 
highly expressed in all phases of the cell cycle (Figure 1C). Moreover, in 
pluripotency states, ESCC miRNAs of respective G1, S and G2/M cell 
phase were located closely together or overlapped in the PCA map, but 
clearly separated after differentiation (Figure 1B). The data indicates that 
most known ESCC miRNAs were independent of cell cycle phase-based 
expression manner to maintain pluripotency in hESCs, whereas ESCC 
miRNAs became more differentially expressed in different cell cycle in 
differentiated hESCs. Thus, although ESCC miRNAs accelerated G1-S 
transition, their expressions are not cell cycle-phase regulated. 
Cell cycle phase-based miRNA profile 
We next characterized miRNA profile from all cell phase-based 
miRNA expression array data. To observe the relationship between 
pluripotent and differentiated hESCs, PCA analysis clearly separated 
pluripotent and differentiated hESC population. However, G1-, S- 
or G2/M-based miRNAs were not integrated but rather separated 
in distance in pluripotent hESCs (Figure 2A), indicating that 
miRNAs of each cell phase were differentially expressed, which was 
a distinctive pattern comparing to G1-, S- and G2/M-ESCC miRNAs 
that were ubiquitously expressed (Figure 1B). HeatMap analysis 
further highlighted some miRNAs were cell cycle-phase differentially 
expressed in both pluripotent and differentiated hESCs (Figures 2B and 
2C). Unlike ESCC miRNAs, which were not cell cycle-phase regulated 
(Figure 1C), this part of the results suggested that there were miRNAs 
that were expressed in a cell cycle phase-dependent manner.
G2/M-miRNAs was a significant component in pluripotent 
hESCs
To further characterize the miRNAs that are differentially expressed 
in different phases of the cell cycle, PCA-SPSS was applied to determine 
the possibility of making a predictive model. From miRNA variables 
among G1, S, and G2/M, the extracted component 1 comprised of G2/
M-miRNAs (Figures 3A and 3B) and explained 48.9% of the variation; 
another component 1 comprised of G1-miRNAs and explained 
33.8% of the variation. Thus, G2/M miRNAs could be a common 
variance among G1, S, and G2/M variables in pluripotent hESCs. In 
differentiated hESCs, levels and expression pattern of miRNAs in the 
G1, S and G2/M were altered with overall decreased miRNA expression 
including G2/M-miRNAs (Figure 2C). PCA-SPSS analysis extracted G1 
miRNAs as component 1 (Figures 3C and 3D) and explained 57.36% 
of the variation. To examine the interrelation among a set of variables 
of G1, S and G2/M miRNAs and extracted significant component 1 
from different cell-phase miRNAs in pluripotent versus differentiated 
hESCs, we demonstrated that G2/M-miRNAs were a statistically 
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significant component among G1, S and G2/M miRNA variables in 
pluripotent state, whereas G1-miRNAs were a significantly component 
in differentiation state. The results suggested that G2/M-miRNAs 
in pluripotency and G1-miRNAs in differentiation might contain 
regulatory messages for pluripotency and differentiation, respectively. 
G2/M-miRNAs consist of miRNAs that target differentiation 
factors
Given that G2/M-miRNAs was a statistically significant component 
in pluripotent hESCs whereas G1-miRNAs became a significant 
component after hESCs differentiation, we hypothesized that in 
pluripotent state G2/M-miRNAs may comprise of miRNAs to maintain 
pluripotency. In differentiation state, G1-miRNA may comprise of 
miRNAs to enhance differentiation. We therefore searched the miRNAs 
that were expressed in either G1 or G2/M phase in undifferentiated 
hESCs but silenced in differentiated hESCs; alternatively, miRNAs 
that were silenced in G1 or G2/M phase in undifferentiated hESCs but 
expressed in G1 or G2/M phase (Supplementary Table 1). Potentially, 
miRNAs expressed in undifferentiated but silenced in differentiation 
states might function to repress differentiation genes (GATA4, GATA6, 
EOMES, GSC and MIXL1) for pluripotency. To search for potential 
targets of the negative regulation by these miRNAs, we used platforms 
of microRNA.org, Targetscan and miRDB. 
Among 22 miRNAs that expressed at G2/M phase in undifferentiated 
hESCs but silenced in differentiated hESCs (Supplementary Table 1), 13 
out of 22 (59%) displayed potential target sites on GATA6 (Table 1), 6 
out of 22 (27%) target sites on GATA4, and 3 out of 22 (13.6%) target 
sites on GSC (data not shown). These G2/M phase-based miRNAs had 
few target sites on EOMES and MIXL1. Among microRNA/mRNA 
prediction methods, miRanda-mirSVR is a regression model for 
predicting the likelihood of target mRNA down-regulation based on 
sequence and structure features, which identifies a significant number 
of experimentally determined non-canonical and non-conserved 
sites. It ranks miRNA target sites by down-regulation score, with the 
suggested mirSVR score cutoff being −0.1 or lower [19,20] (http://www.
microRNA.org). We further detected that 8 out of 22 G2/M-miRNAs 
(36.4%) targeting GATA6 with mirSVR lower than −0.1, ranging from 
−0.11 to −1.348 (Table 1). On GATA6 mRNA, miR-181c, miR-624-5p 
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Figure 1: Cell cycle phase-based ESCC miRNAs profile. (A) Histogram of DNA content of hESCs. G1, S and G2/M cells were sorted out respectively based on the 
histogram of DNA content. (B) PCA pattern to separate ESCC miRNAs between pluripotent and differentiated hESCs. (C) HeatMap to show expression pattern of 
ESCC (including ESCC, ESCC-like and ESCC-variant) miRNAs in G1, S and G2/M cell cycle phases, respectively, in undifferentiated and differentiated hESCs. ESCC 
miRNA were highly expressed in pluripotent hESCs and down regulated in differentiated hESCs in a cell cycle-independent manner.
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and miR-367-5p showed mirSVR score of target sites −1.3481, −1.3421 
and −1.0286, respectively. These mirSVR scores indicated that these 
miRNA sites were expected to be functional sites (Figures 4A-4C). 
On the other hand, only 14.3% of G1-phase miRNAs (expressed at G1 
phase in undifferentiated hESCs but silenced in differentiated hESCs) 
showed target sites on GATA6 with mirSVR score lower than −0.1, 
ranging from −0.111 to −0.649. Thus, compared to G2-phase miRNAs, 
G1-phase miRNAs were less likely functional. 
G1-miRNAs of differentiated hESCs displayed miRNAs 
targeting pluripotency genes
Given that G1-miRNAs were a significant component in 
G1
S
G2/M
G1
S
G2/M
A
CB
Pluripotent
Diﬀerentiated
G1 S G2/M G1 S G2/M
Pluripotent Diﬀerentiated
Figure 2: Cell cycle phase-based miRNA array profile. (A) PCA pattern based on miRNAs array data of cell-phase miRNAs in undifferentiated and differentiated 
hESCs, where the expression of G1-, S- and G2/M-miRNAs in undifferentiated hESCs was distant. (B) HeatMap of G1-, S- and G2/M-miRNAs in undifferentiated 
hESCs. (C) HeatMap of G1-, S- and G2/M-miRNAs in differentiated hESCs.
# of G2/M-miRNAs (Expressed in pluripotency and 
silenced in differentiation)
% of G2/M-miRNAs (Target sites on 
GATA6)
mirSVR score*
<−0.1
mirSVR score
<−1
22 59% (13/22) 36.4% (8/22) 13.6% (3/22)
*miSVR score is an algorithm method for ranking microRNA target sites by down-regulation score
Table 1: Predicted GATA6 target sites of G2/M-miRNAs.
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Discussion
We established cell cycle-based (G1, S and G2/M phases) miRNA 
data set from pluripotent and differentiated hESCs by human miRNA 
array. As expected, ESCC, ESCC-like and ESCC-variant miRNAs were 
highly expressed in pluripotent hESCs and significantly down regulated 
in RA-induced differentiation of hESCs. However, most of ESCC and 
ESCC-related miRNAs showed the pattern of non-cell cycle-regulated. 
Mouse ESCC miRNAs are known to target many inhibitors of the 
G1/S transition including Cdkn1a (p21), Lats2 and Rb1 [8]. More than 
promoting the G1/S transition by targeting CDKN1A, some of human 
ESCC miRNAs target WEE1 (a G2/M checkpoint kinase), Cdk2-
Cyclin D and Cdk4-Cyclin D complex, which result in promoting both 
G2/M and G1/S transition [8]. Moreover, the transcription of ESCC 
Pluripotency state
Diﬀerentiation state
Component 
1 2 
G2/M .856 −.122 
G1 .854 .130 
S .992 
Component 
1 2 
G1 .929  
S .924 −.103 
G2/M .998 
A
C
Rotated component matrix
Rotated component matrix
B
D
Figure 3: Principle component extraction of cell phase variable miRNAs by PCA-SPSS. (A) and (B) Cell cycle phase differentially expressed miRNAs were subjected 
to PCA-SPSS analysis. Although Kaiser-Meyer-Olkin (KMO) Measure of Sampling Adequacy (MCA) was low (0.48), Bartlett’s test sphericity associated p value was 
<0.001 for a valid factor analysis. PCA-SPSS pattern and rotated component matrix showed that G2/M-miRNAs was significant component 1 in pluripotent hESCs. (C) 
and (D) PCA-SPSS pattern and rotated component matrix showed that G1-miRNA was significant component 1 in differentiated hESCs.
3' ugaguggcuguccaACUUACAa 5'
|||||||
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C
Figure 4: Predicted target sites of G2/M-miRNAs miR-181c, miR-624-5p and miR-367-5p on GATA6 3’UTR sequences. (A) Interaction between miR-181c and the 
target site annotated on the 3’UTR of GATA6 and miSVR score prediction by microRNA.org. (B) Interaction between miR-624-5p and target site on the 3’UTR of 
GATA6. (C) Interaction between miR-367-5p and target site on the 3’UTR of GATA6.
differentiation state (Figures 3C and 3D), we next determined the 
G1-mRNAs that were silenced in pluripotent state but expressed after 
differentiation. From miRNA array profile, 12 miRNAs were from silence 
in pluripotency to expression in G1 in differentiation; 2 miRNAs were 
from silence in pluripotency to expression in G2/M in differentiation 
(Supplementary Table 1). We hypothesized that expressed G1-miRNAs 
during differentiation may function to repress pluripotency genes. To 
explore the potential target mRNAs by G1-miRNAs, we found that 
pluripotency genes OCT4, NANOG, and SOX2 all contained target 
sites of G2-miRNA miR-361-3p and miR-186-3p, with Context++ 
percentile 88-95 (TargetScanHuman 7.1). KLF4 contained target sites 
of miR-623 and miR-124. These results suggest that miRNAs that only 
expressed in G1 phase during differentiation might potentially function 
to regulate pluripotency genes negatively. 
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miRNAs is regulated by pluripotency factors such as OCT4, SOX2 and 
NANOG [8]. Thus, even their expression in non-cell cycle phase-based 
pattern, ESCC miRNAs control proliferation, survival, cell cycle and 
pluripotency program of pluripotent stem cells. 
PCA-SPSS is a statistical technique to examine the interrelations 
among a set of variables in order to identify the underlying structure 
of variables. Extracted ‘principle components’ account for most of 
the variance in the original variables. It is a non-parametric analysis 
and the result is unique and independent of any hypothesis for data 
distribution. Using PCA-SPSS to analyse differentially expressed 
miRNAs of G1-, S- and G2/M-cell cycle phase in both pluripotent and 
differentiated hESCs, G2/M-miRNAs were extracted as statistically 
significant component 1 in undifferentiated hESCs. Interestingly, in 
differentiated hESCs, G1-miRNAs were significant component 1, 
whereas G2/M-miRNAs was no longer a significant component. The 
clear shift of significant component 1 of cell-phase miRNAs between 
pluripotency and differentiation suggested that G2/M-miRNAs was 
mostly down-regulated after differentiation. 
The cell cycle machinery and its associated signaling pathways play 
critical roles in regulation of stem cell properties. First is the critical 
link between G1 length and differentiation, when pluripotent cells enter 
into G1, they become “poised” and permissive to either continued self-
renewal or commitment to lineage specification [21]. Secondly, recent 
study has shown that the S and G2 phases are intrinsically associated 
with maintenance of pluripotency, where suppression of regulators 
of the S and G2 phases leading to a rapid decrease in expression of 
pluripotency markers [22,23]. Thus, proposed novel mechanistic model 
is that cell fate specification starts in the G1 phase where hESCs can 
sense differentiation signals; then cell fate commitment is completed in 
G2/M, where pluripotency is dissolved and differentiation completed 
via cell cycle-dependent mechanisms [22,23]. Of miRNA array analysis 
of pluripotent and differentiated hESCs, we identified that cell phase-
based miRNAs displayed distinct features in different hESC states: G2/
M-miRNAs is a significant component in pluripotent hESCs, but G1-
miRNAs is a significant component in differentiated hESCs. Seemingly, 
these characteristics of cell phase-based miRNAs are in accordance with 
pluripotency regulation through cell cycle-dependent mechanisms. 
Moreover, by statistical and computation analysis, we demonstrated 
that G2/M-miRNAs in pluripotent state might comprise miRNAs to 
maintain pluripotency and G1-miRNAs in differentiation state might 
comprise miRNAs to enhance differentiation. The results indicated 
a strong link between bioinformatics and biological understanding 
potential. 
By searching for potential targets for the negative regulation of cell 
phase-based miRNAs, we demonstrated that some G2/M-miRNAs of 
pluripotent hESCs had potential target sites on differentiation factors 
such as GATA6 and GATA4 and G1-miRNAs of differentiation hESCs 
had potential target sites on pluripotency gene OCT4, NANOG, 
SOX2 and KLF4. More importantly, 36.4% of G2/M-phase miRNAs 
comprising target sites on GATA6 were highly possible being functional. 
Therefore, some of cell-phase miRNAs might have potentials to be 
novel miRNAs to regulate pluripotency genes or differentiation factors 
for hESC self-renewal and differentiation, which worth investigations 
of specific miRNA binding sites confirmation and further functional 
study. In summary, our cell cycle phase-miRNA array measurement 
and bioinformatics analysis demonstrated that the G2/M-miRNAs 
could potentially target differentiation factors to maintain pluripotency 
and G1-miRNAs could potentially target pluripotency genes to enhance 
differentiation (Figure 5).
Conclusion
MicroRNAs are one of the important regulators of hPSCs, although 
only 5 clusters of either pluripotency-maintaining miRNAs or 
pluripotency-silencing miRNAs have been identified in hESCs. Through 
statistical and computational analysis of cell cycle-based miRNA arrays, 
we identified G2/M-miRNAs might comprise of miRNAs that target 
differentiation factors and G1-miRNAs might comprise of miRNAs 
that target pluripotency genes. Therefore, from a bioinformatic point 
of view, our study provides novel information on cell phase-based 
miRNAs which regulate pluripotency and differentiation.
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